Oruka Therapeutics Investor Relations Material
Latest events
Q1 2025
9 Jul, 2025
Q4 2024
5 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oruka Therapeutics Inc
Access all reports
Oruka Therapeutics Inc. is a biopharmaceutical company focused on developing innovative treatments for various medical conditions. The company specializes in research and development activities, aiming to address unmet medical needs through advanced therapeutic solutions. Oruka Therapeutics operates within the healthcare sector, leveraging cutting-edge technologies to create potential treatments for patients worldwide. The company is headquartered in Westminster, Colorado, and its shares are listed on the Nasdaq.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
ORKA
Country
🇺🇸 United States